Nanomedicine articles within Nature Communications

Featured

  • Article
    | Open Access

    The delivery of therapeutics using an external trigger is an attractive route for the improvement of targeted disease treatment. Here, the authors have discovered a porphyrin–phospholipid liposome for light-controlled membrane permeabilization and use the system to deliver an anticancer drug in vivo.

    • Kevin A. Carter
    • , Shuai Shao
    •  & Jonathan F. Lovell
  • Article |

    Nanoparticles can deliver drugs to tumours but improvements in selectively targeting tumour cells are required. Here, Mo et al. develop nanocarriers that take advantage of high ATP levels in tumour cells and show that these nanoparticles encapsulating the chemotherapeutic doxorubicin can inhibit tumour growth in mice.

    • Ran Mo
    • , Tianyue Jiang
    •  & Zhen Gu
  • Article |

    The interaction of nanoparticles with target tissues is important in the design of nanoparticle-based therapies. Here, the authors develop a microfluidic chip to assess the interaction of nanoparticles with tumour tissues and demonstrate its capacity to predict in vivonanoparticle behaviour.

    • Alexandre Albanese
    • , Alan K. Lam
    •  & Warren C.W. Chan
  • Article |

    Rapid, highly multiplexed molecular detection platforms may enable more specific and effective disease diagnosis. Here, a solution-based circuit is reported that enables the analysis of samples for panels of pathogens and antibiotic-resistance profiles at clinically relevant levels in less than 2 min.

    • Brian Lam
    • , Jagotamoy Das
    •  & Shana O. Kelley
  • Article |

    Nanoparticles released from living cells can be used as drug delivery vehicles, but scaling up their production is challenging. Here, Wang and colleagues create nanoparticles from natural lipids contained in grapefruit juice that can encapsulate various types of therapeutics and deliver them to cells in vitro and in vivo.

    • Qilong Wang
    • , Xiaoying Zhuang
    •  & Huang-Ge Zhang